Biotech in Belgium: news and updates

bone therapeutics allob allogeneic osteoporosis

News and Trends 19 May 2016

Bone Therapeutics switches to allogeneic for Universal Bone Cell Therapy

Bone Therapeutics is moving forward with a new phase II trial targeting severe osteroporosis – but this time with its allogeneic bone cell therapy (ALLOB). This type of therapy is easier to administrate, and could reach more patients in need. Bone Therapeutics is based in Gosselies (Belgium) and is developing cell therapies to treat conditions […]

May 19, 2016 - 2 minutesmins - By Denise Neves Gameiro

biotech nathalie moll europabio biotechnology

News and Trends 11 May 2016

EuropaBio: “We as an industry should be proud of what we do”

We just partnered with the European Biotech Week, which is a good reason to talk to its secretary general, Nathalie Moll. I asked her more about the event, the reasons for organising it and her vision for the future of Biotech in Europe. The event is a week of Biotech related seminars and activities from September 26th to October 2nd organised by […]

May 11, 2016 - 4 minutesmins - By Philip Hemme

ablynx llama antigody nanobody rsv infant

News and Trends 3 May 2016

Llama Antibody Inhalation gets Positive Results for Respiratory Virus

Ablynx has gotten positive results for its candidate (ALX-0171) in Phase I/IIa trial for infants infected with a life-threatening virus – respiratory syncytial virus (RSV). Located near Ghent (Belgium), Ablynx is making advances in its Nanobody platform, based on the shorter monoclonal antibodies of llamas. Due to their small size, these Nanobodies can be used in a […]

May 3, 2016 - 2 minutesmins - By Denise Neves Gameiro

brain tumor medullablastoma oncurious trial tb 403 neuroblastoma cancer

News and Trends 3 May 2016

Belgian Pediatric Oncology startup Recruits for Brain Tumor Trial

The Belgian biotech startup Oncurious is launching a phase I/IIa trial for an antibody to fight a brain tumor which affects children. Oncurious in Leuven (Belgium) was just launched last April as an emerging oncology company focused orphan drugs for the treatment of pediatric cancers. Its current candidate is preparing for a phase I/IIa trial for the […]

May 3, 2016 - 3 minutesmins - By Dani Bancroft

News and Trends 2 May 2016

Galapagos and AbbVie expand their Cystic Fibrosis collaboration

Galapagos and AbbVie expand their ongoing collaboration in Cystic Fibrosis. With a growth in the portfolio, Galapagos’ milestones increase from €300M to €520M. The most famous collaboration between AbbVie (US) and Galapagos (Belgium) was perhaps their candidate for rheumatoid arthritis – which hit a reef in September, knocking Galapagos’ stock by 39%. But the less […]

May 2, 2016 - 2 minutesmins - By Denise Neves Gameiro

sanofi genzyme antibodies geel pompe leukemia

News and Trends 29 Apr 2016

Big Pharma invest massively in Biomanufacturing facilities

Sanofi is pumping €300M into its current manufacturing site in Belgium. This will support its antibody pipeline, with new laboratories of quality control and manufacturing sciences. Sanofi, France’s largest Pharma, seems to be betting more and more in biologics. Just a few years after buying Genzyme, it’s giving its subsidiary more prominence in their R&D. Now, […]

April 29, 2016 - 2 minutesmins - By Denise Neves Gameiro

bioviva ageing gene therapy telomerase parrish

News and Trends 25 Apr 2016

Anti-ageing DIY Gene Therapy may have worked – to an extent…

The weird tale of BioViva‘s CEO receiving non-approved gene therapy to fight ageing has developed further – now with ‘successful results’, which have been verified by two EU research NGOs. There may be something to it after all? Stopping ageing has always been a dream of mankind – and one that is slowly beginning to […]

April 25, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 22 Apr 2016

Biotech of the Week: Covagen, binding proteins to antibodies for Immunotherapy

We say our goodbyes to Belgium this week and head one more time to Switzerland. In Zürich, where you can find almost any kind of cheese, delicious chocolate and a beautiful view of the Swiss Alps near the city lake, is also where Covagen, our Biotech of the Week is located. City: Zürich (Switzerland) Founded: 2007 Employees: 23 (as of […]

April 22, 2016 - 2 minutesmins - By Joachim Eeckhout

argenx agx115 abbvie immunooncology biotech deal ucl cancer pharma

News and Trends 21 Apr 2016

Llama Biotech makes €600M deal with AbbVie for Immuno-Oncology

Ghent based argenx has just partnered up with the French AbbVie to develop a novel antibody derived from llamas – in its biggest deal ever! Having been better known for their work into autoimmune diseases, argenx has now also broken into the Immuno-Oncology field – big time. Previous collaborators have included Denmark’s Leo Pharma for inflammatory […]

April 21, 2016 - 2 minutesmins - By Dani Bancroft

News and Trends 15 Apr 2016

Biotech of the Week: ThromboGenics & Therapies against Eye Disease

This week, we say Auf wiedersehen to Vienna and move on to the North west. Leuven, the capital city of the Flemish Brabant province in Belgium, fairly close to the country’s capital Brussels. And it is also where ThromboGenics, our Biotech of The Week is located. City: Leuven (Belgium) Founded: 1998 Employees: 85 (including US) Market cap: […]

April 15, 2016 - 2 minutesmins - By Joachim Eeckhout

morphosys galapagos inflammatory mor106 mab

News and Trends 7 Apr 2016

Two of the Biggest European Biotechs launch Antibody Program together

MorphoSys (Germany) and Galapagos (Belgium) have announced a new joint program to conduct a phase I trial for a first-in-class antibody, MOR106, that could be used to treat inflammatory diseases. Just after announcing that it is suing Janssen Biotech and Genmab (Denmark), Munich-based MorphoSys is still keeping things interesting – this time with a phase I trial for […]

April 7, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 29 Mar 2016

Belgian Cell Therapy Biotech Excelling in Trials to Treat Severe Osteoporosis

Bone Therapeutics (Belgium) has released its financial results for 2015, which show a solid cash position and promising results in treating Bone conditions in ongoing clinical trials. This Belgian Biotech is developing cell therapies to treat a bone diseases like osteoporosis with considerable success so far – and 2015 was a year with plenty of important milestones. These […]

March 29, 2016 - 3 minutesmins - By Denise Neves Gameiro

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Belgium

Bone Therapeutics switches to allogeneic for Universal Bone Cell Therapy

EuropaBio: “We as an industry should be proud of what we do”

Llama Antibody Inhalation gets Positive Results for Respiratory Virus

Belgian Pediatric Oncology startup Recruits for Brain Tumor Trial

Galapagos and AbbVie expand their Cystic Fibrosis collaboration

Big Pharma invest massively in Biomanufacturing facilities

Anti-ageing DIY Gene Therapy may have worked – to an extent…

Biotech of the Week: Covagen, binding proteins to antibodies for Immunotherapy

Llama Biotech makes €600M deal with AbbVie for Immuno-Oncology

Biotech of the Week: ThromboGenics & Therapies against Eye Disease

Two of the Biggest European Biotechs launch Antibody Program together

Belgian Cell Therapy Biotech Excelling in Trials to Treat Severe Osteoporosis

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!